China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 28.48
(-1.69%)
CNY 28.48
(-1.69%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.82 Billion CNY | -2.54% |
| 2022 | 8.03 Billion CNY | 5.4% |
| 2021 | 7.62 Billion CNY | 47.75% |
| 2020 | 5.15 Billion CNY | -1.87% |
| 2019 | 5.25 Billion CNY | 3.62% |
| 2018 | 5.07 Billion CNY | 38.25% |
| 2017 | 3.66 Billion CNY | 51.67% |
| 2016 | 2.41 Billion CNY | 10.57% |
| 2015 | 2.18 Billion CNY | 114.99% |
| 2014 | 1.01 Billion CNY | 1.33% |
| 2013 | 1 Billion CNY | 29.21% |
| 2012 | 777.4 Million CNY | 134.76% |
| 2011 | 331.15 Million CNY | 12.17% |
| 2010 | 295.22 Million CNY | -6.7% |
| 2009 | 316.42 Million CNY | 111.97% |
| 2008 | 149.27 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 8.15 Billion CNY | 1.68% |
| 2024 Q2 | 8.02 Billion CNY | 0.38% |
| 2024 Q1 | 7.99 Billion CNY | 2.09% |
| 2023 Q4 | 7.82 Billion CNY | -4.33% |
| 2023 FY | 7.82 Billion CNY | -2.54% |
| 2023 Q1 | 8.19 Billion CNY | 2.03% |
| 2023 Q2 | 8.16 Billion CNY | -0.35% |
| 2023 Q3 | 8.18 Billion CNY | 0.19% |
| 2022 FY | 8.03 Billion CNY | 5.4% |
| 2022 Q1 | 7.67 Billion CNY | 0.76% |
| 2022 Q2 | 7.85 Billion CNY | 2.23% |
| 2022 Q3 | 7.97 Billion CNY | 1.64% |
| 2022 Q4 | 8.03 Billion CNY | 0.67% |
| 2021 Q3 | 5.42 Billion CNY | 2.69% |
| 2021 Q2 | 5.28 Billion CNY | 5.52% |
| 2021 FY | 7.62 Billion CNY | 47.75% |
| 2021 Q1 | 5 Billion CNY | -2.97% |
| 2021 Q4 | 7.62 Billion CNY | 40.53% |
| 2020 Q2 | 5.4 Billion CNY | -2.06% |
| 2020 Q1 | 5.52 Billion CNY | 5.04% |
| 2020 FY | 5.15 Billion CNY | -1.87% |
| 2020 Q3 | 5.31 Billion CNY | -1.68% |
| 2020 Q4 | 5.15 Billion CNY | -2.99% |
| 2019 Q1 | 5.02 Billion CNY | -0.97% |
| 2019 Q3 | 5.17 Billion CNY | 2.16% |
| 2019 Q4 | 5.25 Billion CNY | 1.55% |
| 2019 FY | 5.25 Billion CNY | 3.62% |
| 2019 Q2 | 5.06 Billion CNY | 0.85% |
| 2018 Q3 | 5.19 Billion CNY | 0.99% |
| 2018 FY | 5.07 Billion CNY | 38.25% |
| 2018 Q2 | 5.14 Billion CNY | 36.26% |
| 2018 Q1 | 3.77 Billion CNY | 2.83% |
| 2018 Q4 | 5.07 Billion CNY | -2.3% |
| 2017 Q4 | 3.66 Billion CNY | 23.48% |
| 2017 Q3 | 2.97 Billion CNY | 2.26% |
| 2017 Q1 | 2.77 Billion CNY | 14.62% |
| 2017 Q2 | 2.9 Billion CNY | 4.8% |
| 2017 FY | 3.66 Billion CNY | 51.67% |
| 2016 Q4 | 2.41 Billion CNY | 6.33% |
| 2016 Q2 | 2.21 Billion CNY | 2.88% |
| 2016 FY | 2.41 Billion CNY | 10.57% |
| 2016 Q1 | 2.15 Billion CNY | -1.54% |
| 2016 Q3 | 2.27 Billion CNY | 2.65% |
| 2015 Q2 | 1.09 Billion CNY | 4.24% |
| 2015 Q1 | 1.05 Billion CNY | 3.26% |
| 2015 Q4 | 2.18 Billion CNY | 93.65% |
| 2015 FY | 2.18 Billion CNY | 114.99% |
| 2015 Q3 | 1.12 Billion CNY | 3.15% |
| 2014 FY | 1.01 Billion CNY | 1.33% |
| 2014 Q2 | 929.39 Million CNY | -1.12% |
| 2014 Q4 | 1.01 Billion CNY | 5.16% |
| 2014 Q3 | 967.86 Million CNY | 4.14% |
| 2014 Q1 | 939.92 Million CNY | -6.43% |
| 2013 Q2 | 787.75 Million CNY | 3.25% |
| 2013 FY | 1 Billion CNY | 29.21% |
| 2013 Q4 | 1 Billion CNY | 20.15% |
| 2013 Q3 | 836.01 Million CNY | 6.13% |
| 2013 Q1 | 762.94 Million CNY | -1.86% |
| 2012 FY | 777.4 Million CNY | 134.76% |
| 2012 Q2 | 734.83 Million CNY | -5.53% |
| 2012 Q1 | 777.89 Million CNY | 134.9% |
| 2012 Q4 | 777.4 Million CNY | 2.21% |
| 2012 Q3 | 760.62 Million CNY | 3.51% |
| 2011 FY | 331.15 Million CNY | 12.17% |
| 2011 Q4 | 331.15 Million CNY | 0.0% |
| 2010 FY | 295.22 Million CNY | -6.7% |
| 2009 FY | 316.42 Million CNY | 111.97% |
| 2008 FY | 149.27 Million CNY | 0.0% |